Articles tagged "Kidney transplantation"

2019 American Transplant Congress
Dialysis Facility Profit Status and Referral for Kidney Transplantation
E. R. Walker¹, L. J. McPherson¹, J. C. Gander², S. Pastan¹, R. E. Patzer¹
¹Emory University School of Medicine, Atlanta, GA, ²Kaiser Permanente Georgia, Atlanta, GA
*Purpose: Patients receiving dialysis treatment in for-profit dialysis facilities have historically lower rates of kidney transplantation (KT) compared to non-profit facilities, but the impact of…
2019 American Transplant Congress
Assessment of Serum Tim3 and Gal9 Levels in Predicting the Risk of Infection after Kidney Transplantation
Y. Shi¹, y. li², Y. Li², L. Yan², J. Tang², X. Wu², Y. Bai², Y. An², B. Dai², C. Yang², L. Wang²
¹Department of Nephrology, West China Hospital, Chengdu, China, ²Department of Laboratory Medicine, West China Hospital, Chengdu, China
*Purpose: Infection remains a major cause of morbidity and mortality after kidney transplantation (KT). However, reliable biomarkers to predict the occurrence of post-transplant infection are…
2019 American Transplant Congress
Belatacept Monotherapy in Kidney Transplant Recipients with Failed Allografts Reduces Humoral Sensitization in a Single Center Randomized Controlled Trial
I. R. Badell, R. Elbein, R. A. Bray, H. M. Gebel, A. B. Adams, C. P. Larsen
Emory University School of Medicine, Atlanta, GA
*Purpose: Kidney transplant recipients with failed allografts suffer from high rates of humoral sensitization. Immunosuppression (IS) strategies are highly variable in these patients with many…
2019 American Transplant Congress
Elevated Donor Derived Cell Free DNA (dd-cfDNA) Levels in the Presence of Donor Specific Antibodies (DSA) Are a Strong Predictor of Antibody Mediated Rejection (ABMR) in Pediatric Renal Transplant Recipients
D. Puliyanda¹, R. D. Swinford², H. Pizzo¹, J. Garrison¹, I. Kim¹, A. M. De Golovine², S. Jordan¹
¹Pediatric Nephrology, Cedars-Sinai Med Ctr, Los Angeles, CA, ²Pediatric Nephrology, UTHealth, Houston, TX
*Purpose: A renal biopsy, the gold standard for the diagnosis of antibody mediated rejection (ABMR) in transplant recipients, is invasive and may be associated with…
2019 American Transplant Congress
Impact of Functional Delayed Graft Function in the Modern Era of Kidney Transplantation
D. Cucchiari, A. Molina-Andujar, E. Montagud-Marrahi, J. Rovira, F. Diekmann
Renal Transplant Unit, Hospital Clínic, Barcelona, Spain
*Purpose: the classical definition of Delayed Graft Function (DGF) (i.e. need of dialysis during the first week after kidney transplant) depends on the physician attitude…
2019 American Transplant Congress
The Risk of Systematic Error in Kidney Transplant Opioid Research
J. N. Fleming, N. A. Pilch, S. Ball, P. K. Baliga, V. Rohan, D. J. Taber
Medical University of South Carolina, Charleston, SC
*Purpose: Opioid use before and after kidney transplant is strongly associated with morbidity and mortality; yet data assessing opioid utilization has centered on sources with…
2019 American Transplant Congress
Using Transplant Referral Regions to Measure Access to Kidney Transplant
K. Ross¹, D. Axelrod², R. Patzer¹
¹Emory University, Emory Transplant Center, Atlanta, GA, ²Dept of Surgery, University of Iowa, Iowa City, IA
*Purpose: The transplant community has advocated to emphasize pre-transplant quality metrics to promote access to kidney transplantation (KT). Measuring access to transplant requires a well-defined,…
2019 American Transplant Congress
Impact of Once-Daily Tacrolimus on Trough Concentration Variability in Stable Adolescent and Young Adult Renal Transplant Recipients
M. Moss, J. Goebel, A. Lofton, E. Steinberg, M. Bock
Children's Hospital Colorado, Aurora, CO
*Purpose: High tacrolimus concentration variability (Vtac), likely influenced by medication non-adherence, is a risk factor for graft dysfunction and loss among renal transplant recipients (RTRs),…
2019 American Transplant Congress
Is Alemtuzumab Induction Safe In Septuagenarians Undergoing Deceased Donor Kidney Transplantation?
D. Harriman, V. Gurram, C. Jay, J. Rogers, A. Farney, G. Orlando, A. Reeves-Daniel, A. Mena-Gutierrez, R. Stratta
Wake Forest Baptist Medical Center, Winston-Salem, NC
*Purpose: Alemtuzumab induction in septuagenarians is controversial but understudied.*Methods: Single center retrospective review of adult deceased donor kidney transplant (KT) recipients receiving single dose (30…
2019 American Transplant Congress
Racial and Ethnic Disparities in Access to Living Donor Kidney Transplantation in the US: Have We Made Any Progress among Pediatric Candidates over the Last Twenty Years?
T. Purnell¹, S. Bae¹, X. Luo¹, A. Chen¹, D. Crews¹, L. Cooper¹, O. N. Bignall II², K. Covarrubias¹, D. Segev¹
¹Johns Hopkins School of Medicine, Baltimore, MD, ²Nationwide Children’s Hospital, Columbus, OH
*Purpose: A recent JAMA study demonstrated worsening disparities in access to living donor kidney transplantation (LDKT) among adults in the US. We examined twenty-year trends…